Dr. Laurence chu
Claim this profileGSK Investigational Site
Studies Coronavirus
Studies Gastroenteritis
7 reported clinical trials
8 drugs studied
Affiliated Hospitals
Clinical Trials Laurence chu is currently running
mRNA Vaccine
for RSV
The purpose of this study is to assess the reactogenicity, safety and immune response of various formulations of the RSV mRNA investigational vaccine administered in healthy participants 18-45 years of age.
Recruiting0 awards Phase 12 criteria
mRNA Vaccine
for Flu
The purpose of this study is to assess the safety and immune response of GlaxoSmithKlines (GSK) messenger RNA (mRNA)-based multivalent vaccine (GSK4382276A) candidate against influenza, administered in healthy younger adults (YA) and older adults (OA).
Recruiting1 award Phase 22 criteria
More about Laurence chu
Clinical Trial Related1 year of experience running clinical trials · Led 7 trials as a Principal Investigator · 4 Active Clinical TrialsTreatments Laurence chu has experience with
- XBB.1.5 Vaccine
- NVX-CoV2601 Co-formulated Omicron XBB.1.5 SARS-CoV-2 RS Vaccine
- Prototype/XBB.1.5 Bivalent Vaccine (5 Μg)
- MRNA-CR-04 Vaccine
- Flu Pandemic MRNA Vaccine
- GSK4382276A
Breakdown of trials Laurence chu has run
Coronavirus
Gastroenteritis
Respiratory Syncytial Virus Infection
Respiratory Syncytial Virus
Other Doctors you might be interested in
Frequently asked questions
Do I need insurance to participate in a trial?
Almost all clinical trials will cover the cost of the ‘trial drug’ — so no insurance is required for this. For trials where this trial drug is given alongside an already-approved medication, there may be a cost (which your insurance would normally cover).
What does Laurence chu specialize in?
Laurence chu focuses on Coronavirus and Gastroenteritis. In particular, much of their work with Coronavirus has involved treating patients, or patients who are undergoing treatment.
Is Laurence chu currently recruiting for clinical trials?
Yes, Laurence chu is currently recruiting for 4 clinical trials in Austin Texas. If you're interested in participating, you should apply.
Are there any treatments that Laurence chu has studied deeply?
Yes, Laurence chu has studied treatments such as XBB.1.5 Vaccine, NVX-CoV2601 co-formulated Omicron XBB.1.5 SARS-CoV-2 rS vaccine, Prototype/XBB.1.5 Bivalent Vaccine (5 µg).
What is the best way to schedule an appointment with Laurence chu?
Apply for one of the trials that Laurence chu is conducting.
What is the office address of Laurence chu?
The office of Laurence chu is located at: GSK Investigational Site, Austin, Texas 78705 United States. This is the address for their practice at the GSK Investigational Site.
Is there any support for travel costs?
The coverage of travel expenses can vary greatly between different clinical trials. Please see more financial detail in the trials you’re interested to apply.